COVID-19 Study Impact

The Covid-19 pandemic has caused us to temporarily pause all PREVENT Dementia study visits. The team remain active in continuing to plan for when we can safely re-open our doors to participants and begin welcoming our volunteers back for repeat study assessments.

We are working closely with clinical research teams across all our sites to continually review the situation alongside advice received from government and institutions.

Once it is safe to do so we look forward to inviting our West London group back for the very first of our Visit 3 study time-points, a very exciting milestone for the research! We will also continue to approach all PREVENT participants from our Edinburgh, Cambridge, Oxford and Dublin sites to return for their Visit 2 assessments, around 2 years on first entering the study. We appreciate that timelines may need to be adjusted as a result of this study pause and we thank all of our dedicated volunteers for their patience in these unusual times.

Our face-to-face study visits may necessarily be on hold for now but our momentum to understand the early stage of neurodegenerative diseases and risk factors for dementia will not slow. The PREVENT team continue to work hard analysing all the high quality data collected in the research to date.

We will keep all of our participants up to date as soon as we have any news to share. In the meantime, if you have any questions at all, please do not hesitate to get in touch.

As we are currently working from home, the best way to reach us is by email – 

If you prefer you can call us on 0131 651 7661 and leave a message. The team will respond to all messages as quickly as possible.

Thank you to all our volunteers for your valuable commitment to preventing dementia.

Stay safe,